Close Menu
10 Jogger Slate 8 Womens Mens Inkkas zSqwOH 10 Jogger Slate 8 Womens Mens Inkkas zSqwOH 10 Jogger Slate 8 Womens Mens Inkkas zSqwOH

10 Jogger Slate 8 Womens Mens Inkkas zSqwOH

News on NGS technologies, RNA-seq, clinical sequencing, & sample prep in genetics, genomics, and molecular diagnostics.

The report advises that although sequencing the genomes of infants can be appropriate in some specific cases, we shouldn’t implement large-scale programs to test healthy babies.

The project aims to use circulating tumor DNA to monitor drug response and resistance in metastatic melanoma patients in order to guide treatment decisions.

New Single-Cell Sequencing Methods Aim to Move Beyond Gene Expression

Inkkas 10 Womens Slate 8 Mens Jogger Premium

8 Mens Womens Slate Inkkas Jogger 10 The researchers say that methods that include gene expression as well as other genomic data in one assay could help unravel cell function and gene regulation.

After a series of duplication and rearrangement events, the genes involved in two key pathways producing morphine, codeine, and noscapine have clustered in the genome.

Veracyte said that the draft policy is open to a 45-day comment period and could potentially go into effect in early 2019.

Bladder Cancer Response to Immunotherapy Informed by Expression Profiles

Womens Slate Inkkas Jogger 8 Mens 10
Womens Inkkas Jogger Slate Mens 10 8

Commercial genetic tests are bringing together biological children of fertility doctor who slipped patients his own sperm.

Dreams just might stem from two genes, according to a new mouse study.

The Boston Globe describes facial recognition software designed to help diagnose rare genetic conditions.

Slate Jogger 10 8 Inkkas Womens Mens

The opium poppy genome, gene editing in Duchenne muscular dystrophy, and complex Ewing sarcoma rearrangements.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

Sep
18
Sponsored by
Horizon Discovery

In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls. 

Sep
20
Sponsored by
St. Jude Children's Research Hospital

This webinar will provide an overview of how St. Jude Cloud, a public repository of pediatric cancer genomics data and analysis tools, is impacting cancer research.

Oct
02
Sponsored by
Roche

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.